Better Care is a technology company that develops  innovative software solutions that enable agnostic, centralized and interoperable connectivity of patient-generated clinical data at any point in the care pathway.

Completed 7 one day ago
105 investors
Investment achieved
639.609€
Target
600.000€
Invested
106.6%
106.6% INVESTED
Request a meeting
This campaign was live:
From: 26 September 2023
Until: 21 December 2023
Maturity

In the market

Premoney valuation

10.000.000

Estimated exit

2028

Sector

Digital health

Equity offered

9%

Minimum investment

1.000

Sabadell
Equity L
Tax deduction
close modal

Share this project on your website.

Copy and paste the following code into your content.

Overview: Better Care

Valuation 10.000.000
Estimated return x12
% Offered 9%
Estimated exit 2028

BC Link® reduces the time healthcare professionals spend entering data into the hospital system by 30%. The Oncoheroes team has over 20 years of experience in drug development.

BC Link® supports clinical decisions with our 36 proprietary indicators, that predict adverse events and provide early warnings.

The indicators developed by Better Care can reduce mortality by 3%, increase life years by 0.21 and save €264 per critical patient.

Better Care is a biotechnology company dedicated to the development of innovative software solutions based on artificial intelligence to facilitate and optimize hospital management and clinical practice of the healthcare team, as well as to improve patient diagnosis. The company was founded in 2010 as a spin-off of the Parc Taulí University Hospital in Sabadell, with the aim of supporting healthcare professionals in the processing and interpretation of data generated by medical devices.

Better Care has a unique technology, BC Link®, that enables agnostic, centralized and interoperable connectivity of patient-generated clinical data at any point in the care pathway. This technology connects, integrates and analyzes biomedical data to  provide a complete picture of the patient, facilitating and streamlining informed clinical decisions to optimize patient care.

BC Link® is a vendor-independent system  that connects any medical device on the market with the ability to export information. It is flexible and adapts to the needs of each project, ensuring the interoperability of health information systems. In addition, it captures highly accurate data that provides detailed information on the patient’s status and enables the creation of highly reliable predictive models.

Data captured by  BC Link® can be viewed from Better Care applications such as  BC Mview®, BC Workstation®, BC Sentinel and BC Tracker to support clinical decisions by healthcare professionals across the continuum of care.

Better Care’s motto, “Connecting knowledge”, captures the essence of what we do; connecting the knowledge  extracted from clinical data with the knowledge of healthcare professionals to achieve the best patient care. Better Care has a multidisciplinary team with extensive healthcare experience,, including medical specialists, computer engineers, financial advisors and e-health strategists.

Why is Capital Cell investing in this company?

The term "Big Data" refers to datasets that present challenges in their capture, management, processing, and analysis. In many sectors, it is increasingly common to find technologies that help process, manage, and analyze these data to answer previously unknown questions.

In the field of healthcare, something similar occurs. Hospitals, intensive care units, or operating rooms have numerous medical devices that generate a wealth of useful data that healthcare personnel cannot take full advantage of.

BetterCare has developed BC Link®, an agnostic, flexible, precise, and innovative software that unifies all data from various medical devices. This data integration allows for consolidating all the information in a single real-time platform, resulting in optimization and increased efficiency in hospital processes, reducing the time healthcare professionals spend on data management by 30%.

Furthermore, thanks to its 36 customized indicators and the application of artificial intelligence, BetterCare can predict adverse events and provide early alerts.

Their technology is already being used in 30 hospitals in 12 countries, including renowned national and European medical centers, and they are preparing to expand to the United States and Canada.

Minimum investment: 1.000
Type of exit expected: M&A or licensing
Drag-along rights
Tag-along rights
Tax deductions
Main risks

Legally protecting the intellectual property of BetterCare's software technology can present challenges (but they can be overcome) that prevent an insurmountable barrier to entry for current and future competitors. To maintain a competitive advantage, BetterCare must be able to enter the market and establish a strong presence ahead of its competitors.

Furthermore, accessing markets in other countries, especially the US market, always poses difficulties. It will be crucial for BetterCare to obtain FDA approval and establish relationships with local partners and distributors to facilitate the sale of their technology to US hospitals in a faster and more efficient manner.